Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9

...

Hantavirus outbreak isn't another Covid pandemic – but experts say it's testing U.S. readiness

May 14, 2026

Inside India newsletter: Trump-Xi meeting could test India’s positioning as China counterweight

May 13, 2026

Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight

May 12, 2026

Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance

May 12, 2026

Asia's trillion-dollar titans are powering — and distorting — its fastest growing stock markets

May 12, 2026

Global week ahead: Crude diplomacy casts shadow over Trump-Xi summit

May 10, 2026

CNBC Daily Open: Leadership challenge swirls around Starmer

May 08, 2026

Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

May 07, 2026

CNBC Daily Open: Iran reviews 'one-page peace plan'

May 07, 2026

Inside India newsletter: Social media is reshaping the world's fastest-growing market for global brands

May 06, 2026

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

May 06, 2026

Wegovy sales smash forecasts after pill launch as Novo Nordisk hikes guidance

May 06, 2026

European stocks set to rise as oil prices fall after Trump signals Iran war de-escalation

May 06, 2026

CNBC Daily Open: Kospi bull run rolls on

May 06, 2026

Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk

May 05, 2026

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance

May 04, 2026

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

May 04, 2026

CNBC Daily Open: As Gulf fatigue sets in, earnings take center stage

May 04, 2026

Global week ahead: Is 'Sell in May' just a myth?

May 03, 2026

Weight loss and hair loss: The growing hair treatment market from GLP-1s

May 02, 2026

Apple earnings, DHS shutdown, 'Ozempic breath' and more in Morning Squawk

May 01, 2026

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data

August 26, 2025

Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval

August 26, 2025

A world on weight loss drugs: How GLP-1s are reshaping the economy

August 26, 2025

Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors

August 24, 2025

FDA approves first-ever glucose monitoring system for weight loss from Signos

August 20, 2025

Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data

August 19, 2025

Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk

August 19, 2025

Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

August 18, 2025

5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista

August 07, 2025

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.